45岁及以上的个体接受阿片类抗原剂治疗:一个范围广泛的综述
Zhanna Gaulen1, Linn-Heidi Lunde1, Silvia Eiken Alpers1
1Department of Addiction Medicine, Haukeland University Hospital, 5009 Bergen, Norway.
概括
接受阿片类药物agonist (OAT) 治疗的老年人面临着独特的挑战. 研究必须解决被忽视的社会和心理因素,以改善这个不断增长的人口的福祉.
科学领域:
- 成 药物 药物 药物 药物
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 人口老龄化对阿片类抗原剂治疗 (OAT) 具有独特的考虑.
- 在OAT中45岁及以上的个体更早地经历了与年龄相关的损伤.
- 现有的研究往往忽视了OAT中老年人的特定需求.
研究的目的:
- 探索45岁及以上接受OAT的个人的挑战和需求.
- 确定当前关于这一人口群体的文献中的空白.
- 为未来的研究提供信息,并改善老年人OAT的结果.
主要方法:
- 使用了一个范围审查方法.
- 在主要数据库进行文献搜索:PsycINFO,EMBASE,MEDLINE,CINAHL和科学网.
- 包括28项观察性研究.
主要成果:
- 确定的主要主题包括健康,治疗,物质使用,人口统计和社会方面.
- 与健康和年龄相关的担忧经常被解决.
- 对性别差异,财务问题和心理因素的关注有限.
结论:
- 在了解老年人在OAT中的多方面的需求方面存在重大差距.
- 进一步的研究对于解决社会和心理因素至关重要.
- 扩大研究将提高OAT中老龄化个体的整体福祉.
相关概念视频
Opioid Analgesics: Morphine and Other Natural Cogeners
139
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
139
Opioid Analgesics: Synthetic and Semisynthetic Opioids
173
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
173
Analgesia and Pain Management
399
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
399
Opioid Receptors: Overview
332
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
332
Drug Administration and Therapy Phases: Overview
386
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
386
Drug Dosage Regimen: Overview
3.3K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.3K


